Furthermore, chronic TNF-α exposure to intestinal L cells decreases GLP-1 secretion and anti-TNF-α antibody; etanercept treatment reverses this effect in male mice with high fat diet (HFD)-induced obesity, which enhances the ageing process [6,7]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.